|
OB/GYN Annual Author
Index 2002
[ Subject
| Author ]
[ A | B
| C | D | E |
F | G | H |
I
| J | K | L |
M | N | O | P
| Q | R | S | T
| U | V | W |
X | Y | Z ]
A
Ahranjani M, see Keith
LG
Anderson F, see Kaunitz
AM, Westhoff C
Ansani NT
Effective use of nonsteroidal anti-inflammatory drugs. Nov:25-33
Ansbacher R
Therapeutic substitution of low-dose OCs. Mar:15-16
Armstrong T
Chemotherapy-induced peripheral neuropathy. Feb(suppl):27-30
back to top
B
Baramki T, see Kaunitz
AM, Westhoff C
Baron A, see Fishman
DA
Bear HD
Neoadjuvant chemotherapy. Feb(suppl):12-17
Blickstein I
Multiple pregnancy. Mar:26-30
Bodurtha J
Genetic screening. Nov:44,54
Borgida AF, see Egan
JFX
Bozorgi K, see Fishman
DA
Brown CS
Psychotropic medications, pt 2: use during lactation. Jan:27-38
Brown HL
Cracking genetic code will transform medicine. Feb:42-45
Bueltmann K
Periodontal disease and the female patient. Oct:19-23
Burkman RT
Liability insurance. Aug:8
Patterns in contraception. Dec(suppl):8-11
Rationale for new contraceptive methods. Aug(suppl):4-13
Substantial progress in contraception. Feb:10
Butrick CW
Underlying neuropathology of interstitial cystitis. May(suppl):7-11
See also Sand PK
back to top
C
Carr BR
Family planning. Sep(suppl):31-34
Cauley J
Current and future directions in breast cancer care. Mar(suppl):13-19
See also Nolan TE
Chasen ST
First-trimester ultrasonographic screening for aneuploidy.
Sep:13-18
Chen SH
Recurrent first-trimester pregnancy loss. Dec:39-48
Chervenak FA, see Chasen
ST
Coddington III CC, see Kaunitz
AM, Westhoff C
Cohen HD
Thyroid disorders. Jun(suppl):30-34
Cohen L, see Fishman
DA
Collins JH
Fetal demise from food poisoning. Jul:41
Cramer DW, see Shin
CH
Creinin MD, see Ansbacher
R
back to top
D
Dickerson VM
Patient trust and evidence-based medicine. Nov:11-12
Dominguez L, see Kaunitz
AM, Westhoff C
Donnelly MA, see Fishman
DA
Dore RK
Osteoporosis. Mar(suppl):5-12
See also Nolan TE
back to top
E
Egan JFX
Screening for Down syndrome. Feb:22-30
Elias S, see Phillips
OP
Ellis H, see Mirabile
J
Escudero T, see Chen
SH
back to top
F
Fishman DA
The scientific basis for the accurate detection of early-stage
epithelial ovarian carcinoma, pt 1. Jun:11-15
The scientific basis for the accurate detection of early-stage epithelial ovarian
carcinoma, pt 2. Jul:21-27
Florica JV
Breast mass management. Feb(suppl):6
French JA
Epilepsy and antiepileptic interventions. Sep(suppl):4-9
back to top
G
Gerhard-Herman M
Cardiovascular disease in woman. Jun(suppl):25-29
Giesser B
Multiple sclerosis, pt 1. Sep:24-27
See also Holland N
Gilbert MR, see Armstrong
T
Giordano JL
Breast cancer and sexuality. May:51-52
Sexual dialogue. Jan:44-45
See also Kellogg-Spadt S
Gordon AN
Advances in ovarian cancer. Feb(suppl):22-26
Gorlitsky H, see Pasternack
AS
Goyle V
Queen of rings. Oct:35
Grobman W
Broad-based conversion to elective cesarean delivery is
not justified. May:19,25-28
Guido RS
Abdominal hysterectomy. Aug:15-19
back to top
H
Hendrix SL
The faculty speaks. Nov(suppl):29-31
Implications of the Women’s Health Initiative. Nov(suppl):4-8
The need for evidence-based medicine. Nov(suppl):3
Summarizing the evidence. Nov(suppl):32-34
Herrington DM
Cardiovascular disease. Aug:48-49
Hill WC
Contemporary management of human immunodeficiency virus
during pregnancy. Jul:10-16
Hirsch E
Something’s gotta give. May:10
See also Grobman W, Sand PK
Hodis HN
Estrogen and atherosclerosis. Dec(CME suppl):2-4
Hoffman DE, see O’Grady
JP
Hoffmann H
Re-examining sexual desire. Oct:41-42
Holland N
Multiple sclerosis, pt 2. Oct:24-34
See also Giesser B
Hudson T
Essential fatty acids. Feb:35-41
Premenstrual syndrome, pt 1. May:47-49,59
Premenstrual syndrome, pt 2. Jul:38-40
back to top
J
Jeri AR
The use of an isoflavone supplement to relieve hot flushes.
Aug:35-37
Johnson S
Gynecologic considerations in postmenopausal health. Mar(suppl):27-31
See also Nolan TE
Johnson SR
Vasomotor symptom control. Nov(suppl):9-14
See also Hendrix SL
Justin RG
Listening. Apr:54
back to top
K
Kagan R
Exercise and bone health. Jun:49-50
Kahn BS, see Parsons
CL
Kaliner MA
Recognizing and treating nonallergic rhinitis. Aug:20-32
Kammerer-Doak DN
Surgical treatment of genuine stress urinary incontinence,
pt 1. Oct:11-15
See also Rogers RG
Kaunitz AM
Combination hormone replacement therapy and the Women’s Health Initiative.
Aug:9-10,56
Continuous oral contraceptive use. Apr(suppl):3
Fair access to contraception. Mar:10-11
Regulating menstruation. Apr(suppl):8-11
Successful oral contraceptive use. Dec(suppl):2
Therapeutic options. Apr(suppl):12-16
Three new formulations. Dec(suppl):25-29
Words from our faculty. Apr(suppl):17-22
See also Westhoff C
Keith LG
Educating patients about generic medications. Sep:44-50
Kellogg-Spadt S
Enhancing female orgasm. Mar:43-44
Hypoactive sexual desire. Jun:45-46
Vulvar vestibulitis and sexual pain. Apr:51-53
See also Giordano JL
Kohli N, see Rosenblatt
PL
Krivak TC
Small call ovarian carcinoma. Jan:13-15
back to top
L
Lambrou N, see Mirhashemi
R
Lehman R, see Kaunitz
AM, Westhoff C
Leonhardt KK, see Kaunitz
AM, Westhoff C
Levinduski-Cohen KL, see Cohen
HD
Levine JP
Critical issues in menopause. Dec(CME suppl):1-2
Lindsay MK, see Hill
WC
Litt JZ
Common skin problems in older women. Jun(suppl):35-38
Lu T, see Fishman
DA
Lucas KH
Herbal products. Dec:34-38
Lurain J, see Fishman
DA
back to top
M
Maihle N, see Fishman
DA
Marcovici I
New-onset clitoromegaly associated with Alport syndrome. Nov:52-54
Mattox JH
Chronic pelvic pain of bladder origin. May(suppl):3
See also Sand PK, Stanford EJ
McCullough LB, see Chasen
ST
McManus HM
The Human Genome Project and women’s health. Jul:31-32
McMorris MS, see Revan
VB
McNally EM, see McManus
HM
Meador KJ
Fetal outcomes following antiepileptic drug use. Sep(suppl):10-14
Miesfeldt S, see Paschold
JC
Mirabile J
Adding laser procedures to physicians’ practices.
Jan:39
The cutting edge: laser hair removal. Mar:42
Laser vein removal. Jun:52
Mirhashemi R
Vaginal reconstruction. Sep:38-43
Mishell DR Jr
Meeting today’s contraceptive needs. Aug(suppl):3
The transdermal contraceptive system. Aug(suppl):14-25
Moloney MF
Headaches in the perimenopause. Apr:55-56
Molpus KL, see Stanko
CM
Morrell MJ
Fertility, reproduction, and epilepsy. Sep(suppl):27-30
Hormone effects on seizures. Sep(suppl):15-16,21
Women’s issues in epilepsy. Sep(suppl):3
Mosca L
Cardiovascular disease. Mar(suppl):20-26
See also Nolan TE
back to top
N
Naftolin F
Cognitive function and menopause. Feb:46-47
Nelson AL
DMPA: has it been a decade already? May:57-59
A planned production. Jan:40-41
See also Zieman M
Ninia JG
Obstetric embolic disease. Mar:12-14
Nolan TE
Don’t just complain…write! Sep:11-12
The faculty speaks: a roundtable discussion on postmenopausal health care.
Mar(suppl):32-38
FDA device approval. Apr:13-14
The poor economy will affect us, too. Dec:7
Random thoughts for the New Year. Jan:8-10
The role of HRT and SERMs. Mar(suppl):3-4
Also see Ansbacher R
Novielli KD
Factor V Leiden mutation, venous thromboembolism, and consideration
of hormone therapy. Nov:55-56
Keeping her healthy. Jun(suppl):11
back to top
O
O’Donnell A, see Fishman
DA
O’Grady JP
Use of misoprostol in obstetric practice. Jun:27-35
Oleszczuk JJ, see Keith
LG
Olson GL
Thyroid disease in pregnancy. Apr:31-36
O’Rourke J, see Fishman
DA
O’Shaughnessy JA
Metastatic breast cancer. Feb(suppl):18-21
back to top
P
Parsons A, see Williams
JK
Parsons CL
Prevention of symptom progression. May(suppl):4-6
Tools for diagnosis and treatment. May(suppl):12-17,25
See also Mattox JH, Stanford EJ
Paschold JC
Hereditary breast cancer. Sep:31-36
Pasternack AS
Unusual presentation of sarcoidosis. Jul:28-30
Pector EA
Bereavement in multiple birth, pt 1. Mar:19-25
Bereavement in multiple birth, pt 2. Apr:39-42
Pegram M
The TCH study. Feb(suppl):7-11
Perkins JD
Recurrent posterior vaginal wall abscess. Jan:16
Perlmutter JF, see Sand
PK, Stanford EJ
Perry CP, see Parsons
CL
Pfeifer K, see Fishman
DA
Phillips OP
Cystic fibrosis screening in current practice. Apr:25-28
Raloxifene versus standard hormone replacement. Jun:36-40
SERMs in preventive health care. Nov(suppl):15-16,20-24
See also Hendrix SL
Pope CS, see O’Grady
JP
Purvis JM
Chronic noncancer pain. Jan:21-26
Puscheck E
Images in women’s health. Oct:39-40; Nov:50-51; Dec:53-54
back to top
R
Rardin CR, see Rosenblatt
PL
Revan VB
Management of asthma in pregnancy. Jun:16-26
Robinson JR
Prenatal diagnosis and obstetric management. Sep(suppl):22-26
Rogers RG
Obstetric anal sphincter lacerations, pt 1. Apr:21-24
Obstetric anal sphincter lacerations, pt 2. May:31-36
Surgery for genuine stress urinary incontinence, pt 2. Nov:37-43
See also Kammerer-Doak DN
Rosenblatt PL
Suburethral sling complications. May:37-46
back to top
S
Sable DB, see Chen
SH
Sand PK
Intetstitial cystitis presenting as overactive bladder. May(suppl):13-14
Interstitial cystitis presenting as recurrent urinary tract infection and vulvodynia.
May(suppl):21-22Prophylactic benefits of elective cesarean delivery. May:18,20-24,28
See also Mattox JH, Parsons CL
Schnare SM
Clinician-patient counseling. Dec(suppl):30-32
Schwartz PE, see Fishman
DA
Segal S, see Kaunitz
AM, Westhoff C
Seubert DE, see O’Grady
JP
Shadigian E, see Marcovici
I
Shafer PO, see Carr
BR
Shin CH
Hormone replacement and cancer. Jun(suppl):13-19
Shulman LP
An evolving state. Dec(suppl):19-24
A new era—an old problem. Jun:6
See also Phillips OP, Stanford EJ
Siegel JE
von Willebrand disease and menorrhagia. Dec:15-19
Simon JA
Estrogen, fracture, and colon cancer. Dec(CME suppl):4-6
See also Kaunitz AM
Singh D, see Fishman DA
Skupski DW, see Chasen ST
Small-Pal EJ
Uterine leiomyomas and infertility. Dec:26-33
Smith CV, see Stanko CM
Smith-Levitin M, see Pector EA
Spearman MJ, see Rogers RG
Speroff L
Hormone replacement and breast cancer. Dec(CME suppl):6-7
Splinter MY
Epilepsy in the female patient. Mar:32-39
Stack MS, see Fishman DA
Stanford EJ
Interstitial cystitis presenting as endometriosis. May(suppl):12-13
See also Parsons CL
Stanko CM
Large condylomata acuminata in pregnancy. Aug:41-43
Starz TW
Medical practice: using the right model. Jul:9
See also Ansani NT
Stillman N, see Bueltmann K
Stringer NH
Diagnosis and management of long-term complications of uterine artery embolization.
Nov:13-24
Sun EY, see Revan VB
back to top
T
Taylor RB
The patient from another country. Oct:7-8
Thorneycroft IH
Drospirenone. Apr:45-49
See also Ansbacher R
Thorpe JM Jr, see Ansbacher R
back to top
U
Utian WH
Low-dose ERT/HRT. Jan:42-43
back to top
V
Verp MS
New opportunities in prenatal diagnosis: practical benefits from the Human
Genome Project. Sep:51-53
Vick TM
Routine screening for cervical, breast, and colorectal cancers. Jun(suppl):20-24
Visco FM
Clinical trials. Feb(suppl):3-5
back to top
W
Westhoff C
An overview of menstruation. Apr(suppl):4-7
Words from our faculty. Apr(suppl):17-22
See also Kaunitz AM
Whipple B
Women’s sexual pleasure and satisfaction. Aug:44-47
Wiczyk H, see Small-Pal EJ
Williams JK
Abnormal uterine bleeding. Feb:15-21
Unintended pregnancy. Dec(suppl):3-7
Woodson GC III
Three case studies in advanced disease. Nov(suppl):25-28
See also Hendrix SL
Wysocki S, see Kaunitz AM, Westhoff
C
7back to top
Y
Yerby M, see Meador KJ
back to top
Z
Zieman M
Benefits beyond contraception. Dec(suppl):12-18
Combination OCs and prescribed antibiotics. Mar:40-41
Continuous OC use. Dec:49-50
Contraceptive efficacy and body weight. Oct:36-38
Managing patients using the transdermal contraceptive system. Aug(suppl):26-32
See also Nelson AL
back to top
|
